National Heart, Lung, And Blood Institute Clinical Proteomics Working Group report

scientific article published in April 2004

National Heart, Lung, And Blood Institute Clinical Proteomics Working Group report is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/01.CIR.0000121563.47232.2A
P698PubMed publication ID15078805
P5875ResearchGate publication ID8623769

P50authorChristopher B. GrangerQ62050240
P2093author name stringJennifer E Van Eyk
N Leigh Anderson
Stephen C Mockrin
National Heart, Lung, And Blood Institute Clinical Proteomics Working Group
P433issue14
P407language of work or nameEnglishQ1860
P304page(s)1697-1703
P577publication date2004-04-01
P1433published inCirculationQ578091
P1476titleNational Heart, Lung, And Blood Institute Clinical Proteomics Working Group report
P478volume109

Reverse relations

cites work (P2860)
Q36698789A proteomic primer for the clinician
Q33804131African-American ethnicity is associated with higher plasma levels of D-dimer in adults with hypertension
Q37257354Application of systems biology principles to protein biomarker discovery: urinary exosomal proteome in renal transplantation
Q36764895Associations of candidate biomarkers of vascular disease with the ankle-brachial index and peripheral arterial disease
Q35170187Biomarkers of peripheral arterial disease.
Q47723130Common sense approaches to urinary biomarker study design
Q36735344Cyclic stretch affects pulmonary endothelial cell control of pulmonary smooth muscle cell growth
Q45102946Early detection of acute coronary syndromes and risk stratification by multimarker analysis
Q34129889Early identification of cardiovascular risk using genomics and proteomics
Q33262623Human body fluid proteome analysis
Q34002717Identifying patients at high risk of a cardiovascular event in the near future: current status and future directions: report of a national heart, lung, and blood institute working group
Q24807071Lost in Translation: Obstacles to Translational Medicine
Q36236515Markers for early detection of cardiac diseases
Q30481592Mid-regional pro-adrenomedullin is associated with pulse pressure, left ventricular mass, and albuminuria in African Americans with hypertension
Q36099359Peptides in body fluids and tissues as markers of disease
Q36453377Phospho-proteomic immune analysis by flow cytometry: from mechanism to translational medicine at the single-cell level
Q37068843Pilot proteomic profile of differentially regulated proteins in right atrial appendage before and after cardiac surgery using cardioplegia and cardiopulmonary bypass
Q30477319Plasma C-terminal pro-endothelin-1 is associated with left ventricular mass index and aortic root diameter in African-American adults with hypertension
Q37364330Plasma midregional pro-atrial natriuretic peptide is associated with blood pressure indices and hypertension severity in adults with hypertension
Q28066363Proteomics in India: the clinical aspect
Q36787244Proteomics in atherothrombosis: a future perspective
Q33301686Proteomics in pediatric research and practice
Q39967758Proteomics methods and applications for the practicing clinician
Q48912418Rationale, design, methods and baseline characteristics of the Asklepios Study
Q30479094Relation of plasma midregional proatrial natriuretic peptide to target organ damage in adults with systemic hypertension
Q38814818Renal extracellular vesicles: from physiology to clinical application
Q33530066Sex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease: the Mayo Clinic proteomic markers of arteriosclerosis study
Q36577205Technology Insight: renal proteomics--at the crossroads between promise and problems
Q41702511The association between cigarette smoking and inflammation: The Genetic Epidemiology Network of Arteriopathy (GENOA) study
Q33508672The role of proteomics in the diagnosis and treatment of ovarian cancer
Q36195325The roles of multiple proteomic platforms in a pipeline for new diagnostics

Search more.